Drugs / ZAX.1400.EC.02
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06758752 | Oct 2023 → Dec 2026 expected | atopic eczema | Fasa University of Medical Sciences | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ZAX.1400.EC.02 | “Evaluation of Therapeutic Effects of ZAX.1400.EC.02 a Herbal Compound on Clinical Signs of Skin in Eczema Patients” NCT06758752 ↗ |
| Route | Topical | “ZAX.1400.EC.02, applied topically twice daily for 3 weeks after enrolment” NCT06758752 ↗ |